The translational research conducted in her laboratories ranges from molecular studies in induced-pluripotent stem cells derived myocytes used as a disease model to functional investigations in transgenic animals and to the development of gene therapies. On the clinical end several landmark studies in the field of inherited arrhythmias have identified novel therapies, developed risk stratification schemes and contributed to the definition of clinical management for patients with inherited arrhythmias.